Venture Capital Archives - Page 28 of 105

Vertex Teams Up with Jayson Tatum to Highlight JOURNAVX, a Non-Opioid Pain Medicine

September 23, 2025

Meet the Man Behind FDA-Approved Bladder Cancer Breakthrough: Dr. Purnanand Sarma and the Journey of INLEXZO™

September 22, 2025

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

THIS WEEK'S STORIES

Aera Therapeutics Unveils Preclinical Data, Selects AERA-109 as First Development Candidate for Autoimmune Diseases

September 24, 2025

Cardiosense Names Eric Meizlish CEO to Drive Next Phase of AI-Enabled Cardiac Care

September 19, 2025

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

September 22, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine

Saisei Ventures Names James Feliciano as Venture Partner

Odyssey Therapeutics Secures $213 Million in Oversubscribed Series D to Advance Autoimmune Pipeline

LightSpun Raises $13M to Streamline Dental Insurance With AI

Boomerang Medical Secures $20 Million Series B to Advance Pivotal Neuromodulation Trial in Ulcerative Colitis

Most Read

Bayer Canada Partners with Mint Pharmaceuticals to Distribute ADALAT XL in Canada

Dentsply Sirona and Pearl Partner to Integrate AI Radiologic Support into DS Core

Survey Finds Broad Global Support for Smoke-Free Alternatives to Reduce Smoking

Marginum’s HIVEN Device for Neurosurgery Secures CE Mark Approval at Record Speed

EDITOR PICKS